F. Ramasco , G. Aguilar , C. Aldecoa , J. Bakker , P. Carmona , D. Dominguez , M. Galiana , G. Hernández , E. Kattan , C. Olea , G. Ospina-Tascón , A. Pérez , K. Ramos , S. Ramos , G. Tamayo , G. Tuero , for the ANDROMEDA-SHOCK-2 Spanish Investigators, Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor (SEDAR)
{"title":"Hacia la personalización de la reanimación del paciente con shock séptico: fundamentos del ensayo ANDROMEDA-SHOCK-2","authors":"F. Ramasco , G. Aguilar , C. Aldecoa , J. Bakker , P. Carmona , D. Dominguez , M. Galiana , G. Hernández , E. Kattan , C. Olea , G. Ospina-Tascón , A. Pérez , K. Ramos , S. Ramos , G. Tamayo , G. Tuero , for the ANDROMEDA-SHOCK-2 Spanish Investigators, Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor (SEDAR)","doi":"10.1016/j.redar.2023.07.006","DOIUrl":null,"url":null,"abstract":"<div><p>Septic shock is a highly lethal and prevalent disease. Progressive circulatory dysfunction leads to tissue hypoperfusion and hypoxia, eventually evolving to multiorgan dysfunction and death. Prompt resuscitation may revert these pathogenic mechanisms, restoring oxygen delivery and organ function. High heterogeneity exists among the determinants of circulatory dysfunction in septic shock, and current algorithms provide a stepwise and standardized approach to conduct resuscitation.</p><p>This review provides the pathophysiological and clinical rationale behind ANDROMEDA-SHOCK-2, an ongoing multicenter randomized controlled trial that aims to compare a personalized resuscitation strategy based on clinical phenotyping and peripheral perfusion assessment, versus standard of care, in early septic shock resuscitation.</p></div>","PeriodicalId":46479,"journal":{"name":"Revista Espanola de Anestesiologia y Reanimacion","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0034935623002864/pdfft?md5=9a5077526aeb4b78913431c42a2c3ef6&pid=1-s2.0-S0034935623002864-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Espanola de Anestesiologia y Reanimacion","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0034935623002864","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Septic shock is a highly lethal and prevalent disease. Progressive circulatory dysfunction leads to tissue hypoperfusion and hypoxia, eventually evolving to multiorgan dysfunction and death. Prompt resuscitation may revert these pathogenic mechanisms, restoring oxygen delivery and organ function. High heterogeneity exists among the determinants of circulatory dysfunction in septic shock, and current algorithms provide a stepwise and standardized approach to conduct resuscitation.
This review provides the pathophysiological and clinical rationale behind ANDROMEDA-SHOCK-2, an ongoing multicenter randomized controlled trial that aims to compare a personalized resuscitation strategy based on clinical phenotyping and peripheral perfusion assessment, versus standard of care, in early septic shock resuscitation.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
